Directorate Change
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your PRO notes
Further to the announcement of 1 May 2024 that Paul Quested, Chief Financial Officer, will leave HSS Hire Group Plc ("HSS" or "the Group") at the end of August, HSS announces that Richard Jones has today assumed the role of interim CFO.
Richard has over 13 years of experience in finance roles in UK public and private companies. He is currently Senior Independent Director and Audit Committee Chair of Alliance Pharma Plc and Non-Executive Director of C4X Discovery Ltd and was most recently CFO and Company Secretary of Medica Group Plc. Prior to Medica, Richard was CFO of Mereo Biopharma Plc and previously CFO and Company Secretary of Shield Therapeutics Plc.
Richard will work closely with Paul over the next few weeks to ensure a smooth handover.
The following information regarding the appointment of Richard Crispin Morgan Jones, age 58, is disclosed under Schedule 2(g) of the AIM Rules for Companies:
Current directorships and/or partnerships:
Alliance Pharma Plc
C4X Discovery Ltd
Medica Australia Pty
RCMJ Consultancy Ltd
Former directorships and/or partnerships (within the last five years):
Moonlight Topco Ltd
Moonlight Midco 1 Ltd
Moonlight Midco 2 Ltd
Moonlight Bidco Ltd
Medica Group Ltd (formerly Medica Group Plc)
Medica US Inc
Medica Reporting Finance Ltd
Medica Reporting Services Ltd
Medica Reporting Ltd
Medica IT Services Ltd
Global Diagnostics Ireland Ltd
Global Retinopathy Screening Ltd
JCA Seminars Ltd
Medica US Inc
Med-IDX PTY
Med-IDX UK Ltd
Mereo BioPharma Group Plc
Mereo BioPharma 1 Ltd
Mereo BioPharma 2 Ltd
Mereo BioPharma 3 Ltd
Mereo BioPharma 4 Ltd
Mereo BioPharma Ireland Ltd
Mereo US Holdings Inc
Mereo MereoCo Inc
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.